It has been reported that lost of CD69 enhanced anti-tumor immunity in CD69−/− mice, CD69−/− mice or CD69 antibody significantly inhibited RM-1 prostate carcinoma growth and metastasis [49, 50]. Here, CD69 is linked to prostate carcinoma.